the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy

Summary

To investigate the effectiveness of carbetocin on reducing intraoperative blood loss during abdominal myomectomy

Timeline

Start

2019-09-10

Primary completion

2020-02-10

Completion

2020-02-20

Outcome

Met primary endpoint

paper Carbetocin had significantly lower intraoperative blood loss compared with placebo (mean difference 184 mL). PMID 33461754 ↗

Publications

• Taher A, Farouk D, Mohamed Kotb MM, Ghamry NK, Kholaif K, A Mageed A Allah A, Ali AS, Osman OM, Nabil H, Islam Y, Bakry MS, Islam BA, Alalfy M, Nassar SA, Bosilah AH, Ghanem AA, Ali Rund NM, Refaat R, Abdel Wahed Ali HA, Bakry A, Ashour ASA, Nabil M, Zaki SS. Evaluating efficacy of intravenous carbetocin in reducing blood loss during abdominal myomectomy: a randomized controlled trial. Fertil Steril. 2021 Mar;115(3):793-801. doi: 10.1016/j.fertnstert.2020.09.132. Epub 2021 Jan 16.

Drugs

Indications